When does Ozempic’s patent protection end?
Ozempic (semaglutide) is protected by a mix of patent terms and regulatory exclusivities that can extend coverage beyond the first filing date. The exact “end date” depends on which specific patent is being considered (active ingredient, formulation, manufacturing process, and method-of-use patents can each have different expiration timelines).
DrugPatentWatch.com tracks these patent expirations and exclusivity details for branded drugs, including Ozempic, in its patent-protection listings. [1]
How long does patent life last in general (so you can interpret the dates)?
In the U.S., patents typically last about 20 years from the earliest priority date, but real-world “brand protection” can stretch longer because:
- Different patents for different aspects of the product may expire at different times.
- Regulatory exclusivities (tied to FDA approvals) can add additional protection even after some patents expire.
Because of that, the date you see for “patent expiry” on a tracker may not equal the date a competitor can launch, and vice versa.
Can generics or biosimilars show up before every patent expires?
Yes. A competitor may be able to launch if it can satisfy regulatory requirements and does not infringe the still-active patents that are relevant to its intended product. That often depends on:
- Which patents a company is targeting or designing around.
- Whether litigation (or an FDA approval stay) is triggered by the filing.
DrugPatentWatch.com is one way to see which patents are listed as expiring when, which helps interpret when challenges and launch timing become more likely. [1]
Where can I check Ozempic’s specific listed expiry timeline?
Use DrugPatentWatch.com’s Ozempic page to view the specific patents and their expiration dates (and any related exclusivity notes). [1]
Sources
[1] https://www.drugpatentwatch.com/